脳腫瘍摘出手術が残存腫瘍細胞に及ぼす影響に関する一考察
スポンサーリンク
概要
- 論文の詳細を見る
9L tumor cells were transplanted into the left lobe of the brain in Fischer 344 rats. In one group, the brain tumor was grossly removed from the rats microsurgically on the 14th to 18th day after transplantation (operated group). These rats were decapitated 1, 6, 24, or 48 hr after surgery, having received 250 μc ^3H-thymidine (^3H-TdR) intraperitoneally 30 min before sacrifice. Both frontal lobes (operated left side and non-operated normal side) were removed and DNA was extracted using a modified Schmidt-Thannhauser method. ^3H activity was then measured with a liquid scintillation spectrometer (LSC) to determine the ^3H-TdR uptake into the DNA of the remaining tumor cells. A second group of rats which did not undergo tumor removal (non-operated group) received the same dosage of ^3H-TdR 30 min before decapitation; the brain was removed postmortem, the tumor was then removed from the brain, and the same extraction procedures and uptake measurements were performed. For comparison of the two groups, the relative increased radioactivity (RIRA) in the brain was determined as a ratio of the counts per gram (cpg) in the tissue of the left lobe, from which tumor was removed, to the cpg in the normal right lobe. RIRA in the non-operated group was 5.7, indicating that the ^3H-TdR uptake of tissue in the left lobe, which contained some remaining tumor cells, was 5.7 times higher than that in the normal lobe. In the operated group, RIRA was 1.5 and 1.7 respectively in the rats sacrificed 1 and 6 hr after surgery, which indicated that remaining tumor cells had virtually ceased to proliferate; however, in rats sacrificed 24 hr after surgery, RIRA was 4.9, which approached the same level as that in the non-operated group. In the rats sacrificed 48 hr after surgery, RIRA was as high as 9.5. These results showed that for at least 6 hr after surgery there was almost no proliferation, but by 24 hr after surgery, active division of the remaining tumor cells had resumed. To confirm both ^3H-TdR perfusion in the tissue and tissue permeability, a third group consisting of operated rats received ^3H-TdR and ^<14>C-urea before being decapitated. Both frontal lobes were lyophilized and activities of the ^3H and ^<14>C were measured with LSC. During an observation time of up to 48 hr, there was no significant fluctuation in the level of available ^3H-TdR in tissue or in the tissue permeability, as indicated by ^<14>C-urea space.
- 日本脳神経外科学会の論文
- 1980-04-15
著者
-
小柏 元英
国立精神・神経センター武蔵病院脳神経外科
-
星野 孝夫
カリフォルニア大学サンフランシスコ校脳神経外科 脳腫瘍研究センター
-
村岡 勲
国立精神神経センター脳神経外科
-
村岡 勲
カリフォルニア大学(サンフランシスコ)脳神経外科
-
星野 孝夫
カリフォルニア大学(サンフランシスコ)脳神経外科
-
小柏 元英
カリフォルニア大学(サンフランシスコ)脳神経外科
関連論文
- B-13 側頭葉てんかん手術例での脳磁図の成績
- ヒト脳腫瘍におけるchloroethylnitrosourea 薬剤耐性の評価法 : Northern blot法によるO^6-methylguanine-DNA methyltransferase mRNA 発現量の定量
- Elマウスの硬膜外脳波の基準電極導出法
- Bromodeoxyuridineを用いたヒト脳腫瘍のgrowth fractionの測定
- 1D-8 てんかん患者の脳機能図
- 1F-7 複雑部分発作重積を繰返した3症例 : 連続型重積とサイクル型重積
- 2C-15 生体磁気計測による複雑部分発作の電流源の検討
- 2C-22 Spike-related multi channel analysis of Lennox-Gastaut syndrome
- 孔脳症の1症例
- 抗分裂剤よる脳腫瘍の生長解析
- 2A-3 異所性灰白質と厚脳回症をもち、てんかん発作を合併した1例
- 放射性thymidineによるラット脳腫瘍の標識率の変動に関する解析
- 脳腫瘍摘出手術が残存腫瘍細胞に及ぼす影響に関する一考察
- 側頭葉てんかん手術例での脳磁図の成績(外科治療)
- A-10 発作間歇期棘波の電流源のMEGによる画像化と側頭葉てんかんの所見
- BCNUによる実験脳腫瘍の細胞動態の変化
- 脳腫瘍の生長解析 (中枢神経系の悪性腫瘍)
- 脳腫瘍動物モデルと治療法の考え方
- 1F-11 てんかん患者におけるMRIの有用性